AFP and hepatocellular carcinoma: The last decade has witnessed the selection of three aptamers for AFP; an RNA aptamer with anti-proliferative activity on HCC cells via the downregulation of AFP expression [8] and two DNA aptamers for diagnostic applications [9,10].